DNA-Pharmaceuticals: Formulation and Delivery in Gene Therapy, DNA Vaccination and ImmunotherapyISBN: 978-3-527-31187-3
Hardcover
275 pages
October 2005, Wiley-Blackwell
|
Dr. Martin Schleef studied Biology at the Universities of Würzburg and Bielefeld, Germany and holds a PhD from the University of Bielefeld.
Martin Schleef received post-doctoral training from the Institut Pasteur Paris, France. He joined QIAGEN GmbH, Hilden, Germany in 1994 and is co-founder and CEO of PlasmidFactory in Bielefeld since 2000.
Martin Schleef received post-doctoral training from the Institut Pasteur Paris, France. He joined QIAGEN GmbH, Hilden, Germany in 1994 and is co-founder and CEO of PlasmidFactory in Bielefeld since 2000.